دورية أكاديمية

72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study

التفاصيل البيبلوغرافية
العنوان: 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study
المؤلفون: Malaba, Thokozile R, Nakatudde, Irene, Kintu, Kenneth, Colbers, Angela, Chen, Tao, Reynolds, Helen, Read, Lucy, Read, Jim, Stemmet, Lee-Ann, Mrubata, Megan, Byrne, Kelly, Seden, Kay, Twimukye, Adelline, Theunissen, Helene, Hodel, Eva Maria, Chiong, Justin, Hu, Nai-Chung, Burger, David, Wang, Duolao, Byamugisha, Josaphat, Alhassan, Yussif, Bokako, Sharon, Waitt, Catriona, Taegtmeyer, Miriam, Orrell, Catherine, Lamorde, Mohammed, Myer, Landon, Khoo, Saye, Boffito, Marta, Clayden, Polly, Peto, Tim, Pozniak, Anton, Taylor, Graham, Kambugu, Andrew, Ayabo, Tabitha, Kitaka, Sabrina Bakeera, Byakika-Kibwika, Pauline, Kiiza, Daniel, Kyohairwe, Isabella, Laker, Eva, Luswata, Andrew, Magoola, Johnson, Mayanja, Hamza, Najujuma, Flavia Vivian, Nakijoba, Ritah, Namuddu, Diana, Namuli, Teopista, Ntuyo, Peter, Onzia, Annet, Sempijja, Emmanuel
المساهمون: ViiV Healthcare, Gilead UK and Ireland Corporate Contributions
المصدر: The Lancet HIV ; volume 9, issue 8, page e534-e543 ; ISSN 2352-3018
بيانات النشر: Elsevier BV
سنة النشر: 2022
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s2352-3018(22)00173-4
الإتاحة: https://doi.org/10.1016/s2352-3018Test(22)00173-4
https://api.elsevier.com/content/article/PII:S2352301822001734?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2352301822001734?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.C2A3C1FD
قاعدة البيانات: BASE